Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 5

Endovascular treatment of brain arteriovenous malformations: Our clinical experience

Pages
439–444
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In complex cAVM cases, embolization is thought to provide a high rate of thrombosis or excision of the lesions, reducing the risks of bleeding and other complications before surgical treatment or radiosurgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study is to evaluate the preoperative characteristics and postoperative results of cerebral arteriovenous malformations (cAVM) cases that we treated endovascularly.
📊
Key Findings & Data:However, with the increase of technical developments and professional experience over time; endovascular techniques have started to be the primary treatment method in the treatment of AVMs.
💡
Conclusion & Impact:In complex cAVM cases, embolization is thought to provide a high rate of thrombosis or excision of the lesions, reducing the risks of bleeding and other complications before surgical treatment or radiosurgery.
🔬Design:Review & Systematic Survey
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study is to evaluate the preoperative characteristics and postoperative results of cerebral arteriovenous malformations (cAVM) cases that we treated endovascularly. Endovascular embolization has started to be used as an adjuvant therapy to other treatments in the treatment of cAVM. However, with the increase of technical developments and professional experience over time; endovascular techniques have started to be the primary treatment method in the treatment of AVMs. Materials and Methods: Complaints, angiographic evaluation and treatment data of 12 patients with cAVM who were treated with endovascular methods between January 2018 and December 2020 were retrospectively reviewed. Results: Eight of the patients (66.6%) were male and 4 (33.3%) were female. AVM localizations were cerebral in eleven (91.6%) patients and cerebellar in one (8.3%) patient. According to the Spetzler-Martin grading system; 5 cases (41.6%) were classified as grade 2, 4 cases (33.3%) as grade 3, 2 cases (16.6%) as grade 4 and 1 case (8.3%) as grade 5. During the endovascular treatment procedure, iatrogenic rupture occurred in the AVM nidus in one patient. No other intraoperative or postoperative complications developed in any of the other cases. Total thrombosis was achieved in 5 cases (41.6%) and partial thrombosis in 7 cases (58.3). These 7 cases with partially thrombosis achieved (58.3%), were referred to radiosurgery after endovascular procedure. Total thrombosis was seen in 3 of these 7 patients (42.8%) after radiosurgery. The total thrombosis rate in all cases was 66.6% (n:8). The mean follow-up period was 23.8 months (12-40). Conclusion: Therapeutic embolization may be a viable option for cAVMs in selected cases. In complex cAVM cases, embolization is thought to provide a high rate of thrombosis or excision of the lesions, reducing the risks of bleeding and other complications before surgical treatment or radiosurgery.

🔖

Cite This Article

YÜCE, G., DOĞAN, A. (2022). Endovascular treatment of brain arteriovenous malformations: Our clinical experience. Annals of Medical Research, Cilt: 29 - Sayı: 5, 439–444. https://ajindex.com/articles/445578

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Mouchtouris N, Jabbour PM, Starke RM, et al. Biology of cerebral arteriovenous malformations with a focus on inflammation. Journal of cerebral blood flow and metabolism. 2015;35(2), 167-75
  2. Soulez G, Gilbert MD FRCPC P, Giroux MD FRCPC M, Racicot MD FRCPC J, Dubois J. Interventional Management of Arteriovenous Malformations. Techniques in Vascular and Interventional Radiology. 2019;22(4), 100633
  3. Hernesniemi JA, Dashti R, Juvela S, Väärt K, Niemelä M, Laakso A. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5), 823-9; discussion 829-31
  4. Robert T, Blanc R, Ciccio G, et al. Angiographic factors influencing the success of endovascular treatment of arteriovenous malformations involving the corpus callosum. Journal of neurointerventional surgery. 2015;7(10), 715-20
  5. Berman MF, Sciacca RR, Pile-Spellman J, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000; 47(2), 389-96; discussion 397
  6. Ding D, Starke RM, Kano H, et al. International multicenter cohort study of pediatric brain arteriovenous malformations. Part 1: Predictors of hemorrhagic presentation. Journal of neurosurgery. Pediatrics. 2017;19(2), 127-35
  7. Laakso A, Hernesniemi J. Arteriovenous malformations: epidemiology and clinical presentation. Neurosurgery clinics of North America. 2012;23(1), 1-6
  8. Nataraj A, Mohamed MB, Gholkar A, et al. Multimodality treatment of cerebral arteriovenous malformations. World neurosurgery. 2014;82(1-2), 149-59
  9. Gross BA, Moon K, Mcdougall CG. Endovascular management of arteriovenous malformations. Handbook of clinical neurology. 2017;143, 59-68
  10. Baharvahdat H, Blanc R, Fahed R, et al. Endovascular treatment as the main approach for Spetzler–Martin grade III brain arteriovenous malformations. Journal of NeuroInterventional Surgery. 2021;13(3), 241-6
  11. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. Journal of neurosurgery. 1986;65(4), 476-83
  12. Hoh BL, Chapman PH, Loeffler JS, Carter BS, Ogilvy CS. Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery. 2002;51(2), 303-9; discussion 309-11
  13. Byun J, Kwon DH, Lee DH, Park W, Park JC, Ahn JS. Radiosurgery for Cerebral Arteriovenous Malformation (AVM): Current Treatment Strategy and Radi